IDH-mutant astrocytomas with MMR mutations were significantly more likely to present at higher grade (P < .0001) and had more frequent homozygous CDKN2A deletion (P = .0021) than their MMR wild-type counterparts (Table 1). This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).